patients in england and wales are being denied a lung cancer drug that will be available to hospitals in scotland .
crizotinib can halt the advance of the disease for almost eight months on average .
the scottish medicines consortium -lrb- smc -rrb- is to give the green light for the drug to be used within nhs scotland .